Clinical trials
Terminated Phase 1/2 trials in Austria
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 2 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 20 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Arbeitsgemeinschaft medikamentoese Tumortherapie | 3 |
| Holostem s.r.l. | 2 |
| Ipsen | 2 |
| Amgen | 1 |
| Christoph Aufricht | 1 |
| Hoffmann-La Roche | 1 |
| Incyte Corporation | 1 |
| Lantheus Biosciences Ltd. | 1 |
| Medical University Innsbruck | 1 |
| Merck Sharp & Dohme LLC | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Recurrence | 3 |
| Breast Neoplasms | 2 |
| Carcinoma, Ovarian Epithelial | 2 |
| Leukemia | 2 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 |
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 2 |
| Triple Negative Breast Neoplasms | 2 |
| Adenocarcinoma of Lung | 1 |
| COVID-19 | 1 |
| Carcinoma, Hepatocellular | 1 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.